↓ Skip to main content

Artesunate plus pyronaridine for treating uncomplicatedPlasmodium falciparummalaria

Overview of attention for article published in Cochrane database of systematic reviews, March 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Artesunate plus pyronaridine for treating uncomplicatedPlasmodium falciparummalaria
Published in
Cochrane database of systematic reviews, March 2014
DOI 10.1002/14651858.cd006404.pub2
Pubmed ID
Authors

Hasifa Bukirwa, B Unnikrishnan, Christine V Kramer, David Sinclair, Suma Nair, Prathap Tharyan

Abstract

The World Health Organization (WHO) recommends that people with uncomplicated Plasmodium falciparum malaria are treated using Artemisinin-based Combination Therapy (ACT). ACT combines three-days of a short-acting artemisinin derivative with a longer-acting antimalarial which has a different mode of action. Pyronaridine has been reported as an effective antimalarial over two decades of use in parts of Asia, and is currently being evaluated as a partner drug for artesunate.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 113 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 15%
Student > Bachelor 16 14%
Researcher 16 14%
Student > Master 13 11%
Student > Doctoral Student 9 8%
Other 27 24%
Unknown 16 14%
Readers by discipline Count As %
Medicine and Dentistry 46 40%
Agricultural and Biological Sciences 11 10%
Nursing and Health Professions 8 7%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Psychology 5 4%
Other 18 16%
Unknown 20 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2014.
All research outputs
#3,793,119
of 12,990,632 outputs
Outputs from Cochrane database of systematic reviews
#6,872
of 10,438 outputs
Outputs of similar age
#55,151
of 187,645 outputs
Outputs of similar age from Cochrane database of systematic reviews
#151
of 210 outputs
Altmetric has tracked 12,990,632 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 10,438 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,645 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 210 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.